Research conducted by Dr. Jayne S. Weiss, Professor and Chair of Ophthalmology at LSU Health Sciences Center New Orleans, and colleagues has found that a defect in a gene involved in a rare disease of the cornea also contributes to the progression of i…
Author: The Medical News
Mayo Clinic, Oxford BioMedica collaborate to develop gene therapy for glaucoma
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that it has entered into a research and development collaboration with Mayo Clinic, Rochester (USA) to develop a novel gene therapy for the treatment of chronic gla…
Neutralization approach appears to prevent proliferative vitreoretinopathy
Proliferative vitreoretinopathy (PVR), or the formation of scar tissue within the eye, is a serious, sight-threatening complication in patients recovering surgical repair of retinal detachment. A new study conducted by investigators at the Schepens Eye…
TU/e researcher develops smart eye-surgery robot
Researcher Thijs Meenink at Eindhoven University of Technology (TU/e) has developed a smart eye-surgery robot that allows eye surgeons to operate with increased ease and greater precision on the retina and the vitreous humor of the eye.
Macular degeneration drug may cause increased IOP
Two major drug trials conclude there was little risk from a drug aimed at age-related macular degeneration. Yet a Mayo Clinic ophthalmologist began to note something concerning in some of her patients: an increase in pressure inside the eye. It led to …
More exposure to natural light may reduce rates of nearsightedness
A new analysis of recent eye health studies shows that more time spent outdoors is related to reduced rates of nearsightedness, also known as myopia, in children and adolescents. Myopia is much more common today in the United States and many other coun…
Collagen crosslinking for keratoconus may receive FDA approval in 2012
Patients in the United States who have the cornea-damaging disease keratoconus may soon be able to benefit from a new treatment that is already proving effective in Europe and other parts of the world.
Playing video games may treat amblyopia in children
A new study conducted in an eye clinic in India found that correction of amblyopia, also called “lazy eye,” can be achieved in many older children, if they stick to a regimen that includes playing video games along with standard amblyopia treatment.
Carl Zeiss Meditec to showcase new clinical and productivity tools at AAO annual meeting
Carl Zeiss Meditec will showcase new clinical and productivity tools across the glaucoma, retina, cataract and refractive workplaces during this week’s American Academy of Ophthalmology Annual Meeting in Orlando at booth #821.
Femtosecond laser cataract surgery safe and effective than standard procedure
Two new studies add to the growing body of evidence that a new approach to cataract surgery may be safer and more efficient than today’s standard procedure. The new approach, using a special femtosecond laser, is FDA-approved, but not yet widely availa…
CWRU to lead Cornea Preservation Time Study
Researchers at Case Western Reserve University School of Medicine will lead a national study determining if corneas transplanted up to two weeks after donor death work as well as corneas transplanted up to one week after donor death. The National Eye I…
IRIDEX introduces optional MicroPulse module
IRIDEX Corporation announced today that it has expanded its product offering by introducing an optional MicroPulse module in the Company’s IQ532 (green) laser system and now provides a complete portfolio of infrared, yellow and green laser systems whic…
Topical corticosteroids show promise against bacterial corneal ulcers
A UCSF study gives hope to those suffering from severe cases of bacterial corneal ulcers, which can lead to blindness if left untreated. The use of topical corticosteroids in a randomized controlled trial was found to be neither beneficial nor harmful …
FDA approves Oxford BioMedica’s UshStat IND to treat Usher syndrome type 1B
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration has approved its Investigational New Drug application for the Phase I/IIa clinical development of UshStat, a novel gene-bas…
Action Medical Research announces grants to investigate conditions affecting babies, children
Action Medical Research – the leading UK-wide medical research charity dedicated to helping babies and children – has today announced grants worth more than £1.3 million for top researchers across the country.
GeneDx launches new genetic test to accurately diagnose rare diseases
At the joint conference of the American Society of Human Genetics/International Congress on Human Genetics in Montreal on October 12, GeneDx, one of the foremost genetics laboratories in the world and a subsidiary of Bio-Reference Laboratories, Inc., i…
Children under the age of 3 with NLDO more likely to develop amblyopia
Amblyopia, sometimes referred to as “lazy eye,” is a cause of poor vision in children. It occurs in about 1.6% to 3.6% of the general population. Early treatment is critical, as the first few years are the most important in the development of eyesight….
British scientist wins NYSCF – Robertson Stem Cell Prize
The New York Stem Cell Foundation (NYSCF) announced today that a British stem cell scientist working to cure blindness will be the first recipient of The New York Stem Cell Foundation – Robertson Prize in Stem Cell Research, a $200,000 prize awarded an…
Study: Emerging pharmaceutical platform may produce undesirable effects on eye function
According to new research by University of Kentucky investigators, an emerging pharmaceutical platform used in treating a variety of diseases may produce unintended and undesirable effects on eye function.
Three Penn labs receive NIH grant to speed translation of medical research into patient care
Three labs from the University of Pennsylvania have received $12.5 million from the National Institutes of Health (NIH) as part of its $143.8 million national grant program to challenge the scientific status quo with innovative ideas that have the pote…